Serovar distribution, antimicrobial resistance profiles, and PFGE typing of Salmonella enterica strains isolated from 2007–2012 in Guangdong, China by Bixia Ke et al.
RESEARCH ARTICLE Open Access
Serovar distribution, antimicrobial resistance
profiles, and PFGE typing of Salmonella enterica
strains isolated from 2007–2012 in Guangdong,
China
Bixia Ke1†, Jiufeng Sun1,2†, Dongmei He1, Xiaocui Li1, Zhaoming Liang1 and Chang-wen Ke1*
Abstract
Background: Salmonella enterica includes the major serovars associated with human salmonellosis. In this study, 1764
clinical Salmonella enterica isolates from diarrhea outpatients were collected from fifteen cities in Guangdong province,
China, between 2007 and 2012. These isolates represent all of the Salmonella isolates collected from the province during
that period.
Methods: The isolates were characterized by serovar determination, antimicrobial susceptibility tests and PFGE fingerprint
typing.
Results: The serovar distribution results demonstrated that Salmonella Typhimurium (n = 523, 29.65%) and Salmonella
4,5,12:i:- (n = 244, 13.83%) are the most common serovars causing infant salmonellosis, whereas Salmonella Enteritidis
(n = 257, 14.57%) mainly causes human salmonellosis in adults. The serovar shift from Salmonella Enteritidis to Salmonella
Typhimurium occurred in 2008. Antimicrobial susceptibility data showed a high burden of multidrug resistance (MDR)
(n = 1128, 56.58%), and a 20%-30% increase in the number of isolates resistant to ciprofloxacin (n = 142, 8.05%) and
third-generation cephalosporins (n = 88, 4.99%) from 2007–2012. Only 9.97% of isolates (n = 176) were fully susceptible
to all agents tested. A high burden of MDR was observed in Salmonella Typhimurium and Salmonella 4,5,12:i:- for all
age groups, and a reduced susceptibility to third-generation cephalosporins and quinolones occurred particularly in
infants (≤6 years). The dominant PFGE patterns were JPXX01.GD0004, JEGX01.GD0006-7 and JNGX01.GD0006-7. ACSSuT
was the predominant MDR profile in the Salmonella Typhimurium & 4,5,12:i:- complexes, while ASSuT-Nal and ASSu-Nal
were the major MDR profiles in Salmonella Enteritidis. The predominant PFGE patterns of the Salmonella Typhimurium
& 4,5,12:i:- complexes and Salmonella Stanley were most prevalent in infants (≤6 years). However, no obvious
relationship was observed between these PFGE profiles and geographic location.
Conclusions: These data reveal the serovar distribution of isolates recovered from diarrhea patients, the characteristics
of resistant strains and fingerprint typing in Guangdong from 2007 to 2012. These results highlight a serovar shift and a
worrying percentage of MDR strains with increasing resistance to quinolones and third-generation cephalosporins.
Thus, continued surveillance of Salmonella and their MDR profiles using combined molecular tools and efforts to
control the rapid increase in antimicrobial resistance among Salmonella in Guangdong are needed.
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Background
The genus Salmonella currently includes two species, Sal-
monella enterica and Salmonella bongori. Salmonella
enterica is further divided into subspecies I (enterica), II
(salamae), IIIa (arizonae), IIIb (diarizonae), IV (houtenae),
and VI (indica). Serotyping is the traditional method for
the subtyping and the differentiation of Salmonella iso-
lates based on the Kauffmann–White scheme. Over 2500
Salmonella serotypes are currently known [1]. Salmonella
enterica, the etiological agent of salmonellosis, is recog-
nized as an endemic food-borne pathogen that causes a
heavy global socioeconomic burden [2-4]. Salmonella
enterica infections result in diverse clinical manifestations.
Typhoid fever, caused by Salmonella Typhi and Salmon-
ella Paratyphi, is a bacteremic illness which occurs in
strong, healthy hosts in addition to immunocompromised
hosts and infants and is essentially dependent on the bac-
terial inoculum/infectious dose [5]. Non-typhoidal Salmon-
ella (NTS) serovars (e.g., Salmonella Enteritidis, Salmonella
Typhimurium and Salmonella 4,5,12:i:-) normally cause
self-limiting diarrhea or gastroenteritis, which results in a
significant disease burden, with an estimated 2.8 million
cases of diarrhea and 93.8 million cases of gastroenteritis,
worldwide, and 155,000 deaths each year [6]. The host
range of NTS serovars is broad, including poultry and
cattle. Infection caused by NTS is commonly due to
contamination in the food chain and food poisoning in
developing countries. Occasionally, NTS serovars cause
secondary bacteremia, while in immunocompromised
patients in sub-Saharan Africa, they cause high rates of
bacteremia in children below 5 years old as well as those
with HIV infection [5,6].
Typhoid Salmonella caused 216,000 deaths globally in
2010 [2], whereas most cases of invasive, non-typhoid
salmonellosis occur occasionally and are due to either
Salmonella Typhimurium or Salmonella Enteritidis [7].
The resistance of NTS to ampicillin, chloramphenicol
and sulphamethoxazole is usually high in Africa and the
USA [8,9]. The treatment of NTS, therefore, increas-
ingly relies on fluoroquinolones or third-generation
cephalosporins; however, these treatment options are
threatened by reduced bacterial susceptibility to fluoro-
quinolones and extended-spectrum beta-lactam antibi-
otics, respectively [9,10]. In Hong Kong, China, the rate of
infections by NTS has been increasing since 1989, and the
most common Salmonella serovar is Enteritidis [11]. The
antimicrobial susceptibilities of 275 Salmonella Enteritidis
strains isolated from 1986 to 1996 show that over 99% of
the isolates are susceptible to 17 of the 19 antimicrobial
agents tested [12]. From 2005 to 2010, Salmonella Enteri-
tidis was the predominant serovar in Hong Kong; in that
time, the strains that were not susceptible to ciprofloxacin
increased significantly, from 39.3% to 63%, and the per-
centage of multidrug resistant (MDR) strains increased
from 17.8% to 36.2% [13]. In an inland province, Henan, the
two most common serovars among the isolates collected
during 2006 and 2007 were SalmonellaTyphimurium (27%)
and Salmonella Enteritidis (17%) [14]. Our previous study
on Salmonella infection in diarrhea patients in Guangdong
province showed that Salmonella Typhimurium and Enteri-
tidis were the most common serovars. Eighty percent of the
229 isolates were susceptible to cephalosporins and quino-
lones, while 59.3% of them were multidrug resistant strains
[15-18]. However, these studies did not provide sufficient in-
formation concerning prevalence, serovar distribution, and
antimicrobial susceptibility in Guangdong province. Re-
duced quinolone- and third-generation cephalosporin- sus-
ceptibility in NTS is also poorly documented [10,19].
The current study describes serovar profiles and poten-
tial profile shifts, characterizes MDR isolates with a special
focus on susceptibility to quinolones and third-generation
cephalosporins and reveals associations between MDR
profiles and PFGE fingerprint pattern.
Methods
Ethics statement
Ethical approval was granted by the Ethical Committee
of the Guangdong Provincial Center for Disease Control
and Prevention. The present study complies with the
World Health Organization and international guidelines
on global surveillance [20]. The data have been reviewed
and analyzed anonymously.
Sampling, bacterial culture and identification
According to the Global Salmonella Surveillance program,
all the cities in Guangdong Province were included in this
system (Figure 1), while 15 of 21 cities submitted the sam-
ples to our center for Salmonella surveillance. The recruit-
ment of patients followed specific guidelines. Patients who
had two of the following three symptoms were chosen for
the study: 1) diarrhea more than three times within 24 hours,
with watery stools; 2) fever > 38°C, headache, chills, malaise;
3) diarrhea with vomiting, abdominal pain, and watery
stools. Stool samples were collected from clinical diarrhea
outpatients of hospitals in fifteen cities from 2007 to 2012
(Figure 1). All of the samples (42,889) were cultured in
local hospitals using solid broth agar media (Huankai,
Guangzhou, China) for the initial evaluation of Salmon-
ella growth, and then suspicious colonies were picked
into vials containing semi-solid Rappaport Vassiliadis
Medium (OXOID, France), and shipped to Guangdong
Provincial Center for Disease Control and Prevention
(Guangzhou, China) at room temperature, where they
were incubated daily and checked for growth. The cultures
that grew were Gram stained, subcultured and identified
at the species level by standard biochemical methods, in-
cluding the characteristic growth on Kligler Iron Agar
(Huankai, Guangzhou, China), tests for urease, oxidase, b-
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galactosidase and indole production, and positive tests for
lysine decarboxylase (the technician training course was
first launched on Apr, 2007, and updated on Sep, 2009). In
total, 1764 stool samples showed positive results for Sal-
monella growth. The serovar of the Salmonella isolates was
confirmed by slide agglutination with commercial mono-
specific anti-sera (Sifin, Berlin, Germany), following the
White-Kauffmann-Le Minor scheme [21]. The outbreak
isolates were collected separately, and all the strains col-
lected as described above were considered epidemiologi-
cally unrelated. Age, gender and geographic origin were
recorded as part of the standard information present on the
laboratory request forms.
Antimicrobial susceptibility
The antimicrobial susceptibility test was performed accord-
ing to the guidelines of the Clinical and Laboratory Stan-
dards Institute (CLSI) [22]. The agar diffusion assays were
performed on Muller-Hinton agar with disks containing
seven classes of antimicrobial agents (aminoglycoside,
cephalosporin, penicillin, quinolone, tetracycline, ampheni-
col, and sulfonamide). The specific antimicrobials used
were: streptomycin 10 μg (S), gentamicin 10 μg (G), ceftazi-
dime 30 μg (Caz), cefotaxime 30 μg (Ctx), cefepime 30 μg
(Fep), ampicillin 10 μg (A), nalidixic acid 30 μg (Nal), cipro-
floxacin 5 μg (Cp), tetracycline 30 μg (T), chloramphenicol
30 μg (C), sulfamethoxazole 300 μg (Su), and trimethoprim
5 μg (Tm). The results were interpreted as resistant, inter-
mediate or susceptible, according to the CLSI guidelines
[22]. Escherichia coli ATCC25922 was used as quality con-
trol organism. MDR was identified as resistance to more
than three classes of antimicrobials. The antimicrobial re-
sistance pattern and the sources of the strains are shown in
Additional file 1: Table S1.
Pulsed field gel electrophoresis
The pulsed field gel electrophoresis (PFGE) results
were taken from the routine surveillance data in our
lab. PFGE was performed according to the PulseNet
protocol for Salmonella [23], using XbaI as restriction
Figure 1 Locations where clinical diarrhea outpatients collected in Guangdong Province (marked with green color). The 15 isolation sites are
marked in red and black dots in Guangdong Province, China. International borders and location of Guangdong province are also shown in the figure.
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enzyme (New England Biolabs, Leusden, The Netherlands).
The cluster analysis was performed with Bionumerics 5.1
(Applied Maths NV, Sint-Martens-Latem, Belgium) using
the Dice similarity coefficient and UPMGA (unweighted
pair group method using average linkages) dendrogram
type (optimization 0.50%, position tolerance 1.50%).
Data analysis
All data were entered in an Excel database (Microsoft Cor-
poration, Redmond, Washington, USA). Proportions were
assessed for statistical significance using the Chi square test
or Fisher’s exact test, considering p < 0.05 as significant. If
the data were normally distributed, the mean values of two
groups were compared with Student’s t-test; otherwise, me-
dian values were compared with the Mann–Whitney rank
sum test (Stata 10, Stat Corp, Texas, USA).
Results
Serovars and epidemiological data
In total, 1,764 Salmonella isolates were successfully isolated
from 42,889 stool samples, which were collected from diar-
rhea outpatients in 15 cities in Guangdong Province from
2007–2012 (Additional file 1: Table S1). The serovar identi-
fication showed that these isolates could be classified into
128 serovars. The most prevalent strains isolated during the
test period were NTS (Table 1). The predominant NTS
consisted of Salmonella Typhimurium (n = 523, 29.65%),
Salmonella Enteritidis (n = 257, 14.57%), Salmonella 4,5,12:
i:- (n = 244, 13.83%), Salmonella Stanley (n = 167, 9.47%),
Salmonella Derby (n = 46, 2.61%), Salmonella Rissen (n =
36, 2.04%), Salmonella Weltevreden (n = 35, 1.98%), Sal-
monella Infantis (n = 28, 1.58%), Salmonella Agona (n = 24,
1.36%), Salmonella Albany (n = 22, 1.25%) and Salmonella
Newport (n = 19, 1.08%) (Table 1). The incidence of Sal-
monella infections caused by the top 11 NTS serovars (n =
1401, 79.42%) showed an increasing trend from 2007 to
2012, except for SalmonellaTyphimurium in 2010 (Table 1).
In 2007, Salmonella Enteritidis was the major causative ser-
ovar in diarrhea outpatients (n = 14, 26.4%), while in 2008,
Salmonella Typhimurium (n = 20, 29.85%) became more
frequently isolated than Salmonella Enteritidis (n = 17,
25.30%). From that point, Salmonella Typhimurium and
Salmonella 4,5,12:i:- were the predominant endemic sero-
vars in diarrhea outpatients in Guangdong (Figure 2).
The male/female ratio of the patients was 1.37 (1020 male,
744 female). The age distribution of the patients with the
predominant Salmonella serovars is illustrated in Figure 3.
The median patient age was 0.92 years (interquartile range:
0.58–4 years). The age-associated stratified analysis showed
that Salmonella Typhimurium and Salmonella 4,5,12:i:-
were the predominant infectious agents in infants (<6 years),
whereas Salmonella Enteritidis was the predominant serovar
in adults (>15 years). However, there was no statistically sig-
nificant difference between the median age of Salmonella
Typhimurium, Salmonella 4,5,12:i:- and Salmonella Enteriti-
dis patients (p > 0.05, Mann–Whitney Rank Sum Test).
Antimicrobial susceptibility
The antimicrobial resistance profiles are shown in
Additional file 1: Table S1. Of all the isolates, 63.49%,
59.97%, 59.64%, 58.78% and 49.77% (n = 1120, 1058,
1052, 1037 and 878) of the isolates were resistant to
sulfamethoxazole, tetracycline, nalidixic acid, ampicillin
and streptomycin, respectively (Table 2). Four of the
Table 1 Distribution of the predominant serovars of 1764 Salmonella enterica isolates from humans with infections in
Guangdong Province, China from 2007 to 2012
Salmonella enterica serovars 2007 2008 2009 2010 2011 2012 In total % of total isolates
Enteritidis 14 17 28 31 48 119 257 14.57
Typhimurium 8 20 40 129 110 216 523 29.65
1,4,5,12:i:- 0 6 4 16 79 139 244 13.83
Stanley 3 5 14 14 38 93 167 9.47
Derby 2 3 2 7 9 23 46 2.61
Rissen 0 0 0 0 12 24 36 2.04
Weltevreden 0 0 2 9 7 17 35 1.98
Infantis 0 0 3 4 12 9 28 1.58
Agona 1 2 4 0 3 14 24 1.36
Albany 0 1 1 5 6 9 22 1.25
Newport 1 0 3 6 0 9 19 1.08
Typhi 0 0 1 1 1 1 4 0.23
Paratyphi(A + B + C) 1 (B) 0 3(B) 5(2A + 2B + 1C) 3(B) 12(3A + 9B) 24 1.36
other 114 NTS serovars 23 14 26 54 61 158 335 18.99
Total 53 68 131 281 389 843 1764 100
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twelve antimicrobial agents, ceftazidime, cefotaxime, ce-
fepime and ciprofloxacin, showed high susceptibility
(>90%), while the trend for increased resistance was much
greater for these four agents than for the other eight drugs
(20-30%) (Figure 4A, red axis). Within typhoid Salmonella,
four of twenty-eight isolates were MDR strains, while only
ESS12371 and ESS12984 were resistant to ciprofloxacin
and cephalosporins (ceftazidime, cefotaxime and cefepime),
respectively (Additional file 1: Table S1). In the NTS iso-
lates, the proportion of Salmonella Typhimurium and
Salmonella 4,5,12:i:- resistant to trimethoprim, tetracyc-
line, gentamicin, chloramphenicol, cefotaxime and cip-
rofloxacin were significantly higher (p < 0.05) than
Salmonella Enteritidis (Table 2). However, 8.05% of all
isolates (n = 1764), showed a reduced susceptibility to
ciprofloxacin (Salmonella Typhimurium [n = 60], Sal-
monella 4,5,12:i:- [n =28], Salmonella Enteritidis [n =
11], Salmonella Stanley [n = 8] and other 21 serovars
[n = 35]) (Table 2), whereas 4.99% (88/1764) of them
were resistant to ceftazidime, cefotaxime and cefepime
at same time. Resistance to cefepime alone occurred in
9.58% of the isolates (169/1764, Salmonella Typhimur-
ium [n = 69], Salmonella 4,5,12:i:- [n = 29], Salmonella
Enteritidis [n = 18], Salmonella Stanley [n = 9] and other
24 serovars, [n = 44]) (Table 2).
MDR occurred in 56.51% (997/1764) of all isolates. The
reduced susceptibility was observed in all tested anti-
microbial agents from 2007 to 2012 with few exceptions
(Salmonella Enteritidis from 2008 to 2010 and Salmonella
Stanley from 2007 to 2008) (Figure 4B). The proportion of
MDR isolates increased yearly in Salmonella Typhimur-
ium and Salmonella 4,5,12:i:- (>80%), while this propor-
tion declined in Salmonella Enteritidis. The ACSSuT is
the most prevalent MDR pattern (27.04%, 477/1764), par-
ticularly in Salmonella Typhimurium and Salmonella
4,5,12:i- (74.42%, 291/391). Two Salmonella Typhimurium
and one Salmonella 4,5,12:i:- isolate(s) resistant to all
twelve antimicrobial agents were obtained (marked red
in Additional file 1: Table S1). Only 9.97% (176/1764) of
isolates were fully susceptible to all tested agents
(Table 2). The ratio of MDR between the sampling loca-
tions was comparable (46.5-71.4%) (Table 2). No obvi-
ous relationships between MDR or resistance to single
antimicrobial agents and sampling area were observed
within these isolates.
The age-associated stratified analysis showed severe
MDR in Salmonella Typhimurium and Salmonella 4,5,12:
i:- for all age groups, which was even worse in infants. Re-
duced susceptibility occurred in infants for the tested third-
generation cephalosporin and quinolone (Figure 4C).
Figure 2 The proportion of top 5 serovars among the total isolates from 2007 to 2012. Each data point means the proportion of each
serovar in the present year (indicated as percentage in Y-axis), different serovars are indicated using different symbols as illustrated in figure.
Figure 3 The prevalence of top 5 serovars among the total isolates within different age groups. Less than one years old (<1): newborn
baby group; between 1 and 6 years old (1–6): Infants group; between 7 and 15 years old (7–14): juvenile; between 15 and 64 years old (7–14):
adults group; more than 65 years old (>65): elderly group. The “▲” mark the predominant serovar in less than 6 years old group, and “♦” indicate
the most prevalent serovar in adults.
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Table 2 Antimicrobial susceptibility among 1764 Salmonella enterica isolates from humans with infections in Guangdong province, China, during 2007 and
2012, and MDR in each of the top 11 serovars































Enteritidis 257 143(55.64) 11(4.28) 14(5.45) 18(7.01) 212(82.49) 11(4.28) 141(54.86) 23(89.49) 76(29.57) 23(8.95) 110(42.81) 10(3.89) 116(45.14)
Typhimurium 523 453(86.62) 43(82.21) 68(13.01) 69(13.19) 437(83.56) 60(11.47) 455(86.99) 337(64.44) 457(87.38) 340(65.01) 391(74.76) 381(72.85) 454(86.80)
1,4,5,12:i:- 244 220(90.16) 18(7.37) 30(12.29) 29(11.88) 182(74.59) 28(11.47) 220(90.16) 128(52.46) 228(93.44) 141(57.78) 164(67.21) 164(67.21) 218(89.34)
Stanley 167 14(8.38) 10(5.99) 11(6.58) 9(5.39) 19(11.37) 8(4.79) 35(20.96) 14(8.38) 20(11.98) 13(7.78) 25(14.97) 13(7.78) 18(10.78)
Derby 46 15(26.08) 2(4.35) 3(6.52) 3(6.52) 17(36.96) 4(8.69) 35(76.08) 14(30.44) 22(47.83) 14(30.44) 19(41.30) 16(34.78) 15(32.61)
Rissen 36 26(72.22) 3(8.33) 5(13.89) 6(16.67) 5(13.89) 1(2.78) 23(63.89) 30(83.33) 31(86.11) 7(19.44) 16(44.44) 5(13.89) 15(41.67)
Weltevreden 35 3(8.57) 2(5.71) 2(5.71) 2(5.71) 4(11.43) 1(2.86) 8(22.86) 4(11.43) 6(17.14) 3(8.57) 6(17.14) 2(5.71) 3(8.57)
Infantis 28 23(82.14) 0 3(10.71) 2(7.14) 23(82.14) 0 23(82.14) 19(67.86) 19(67.86) 4(14.28) 4(14.28) 21(75) 21(75)
Agona 24 4(16.67) 0 1(4.17) 3(12.5) 4(16.67) 3(12.5) 7(29.17) 3(12.5) 8(33.33) 4(16.67) 5(20.83) 5(20.83) 6(25)
Albany 22 21(95.45) 3(13.63) 4(18.18) 4(18.18) 20(90.9) 1(4.54) 22(100) 20(90.9) 21(95.45) 4(18.18) 7(31.81) 21(95.45) 20(90.9)
Newport 19 3(15.79) 2(10.53) 1(5.26) 0 4(21.05) 1(5.26) 5(26.31) 3(15.79) 6(31.57) 2(10.53) 5(26.31) 3(15.79) 4(21.05)
Typhi 4 1(25) 0 1(25) 0 1(25) 0 1(25) 1(25) 1(25) 1(25) 1(25) 1(25) 1(25)
Paratyphi
(A + B + C)




335 106(31.64) 28(8.35) 32(9.55) 23(6.86) 119(35.52) 23(6.86) 141(42.09) 106(31.06) 161(31.64) 54(16.11) 121(36.11) 72(21.49) 103(30.74)
Total
(% resistance)b
1037(58.78) 124(7.03) 176(9.98) 169(9.58) 1052(59.64) 142(8.05) 1120(63.49) 702(39.79) 1058(59.97) 611(34.64) 878(49.77) 714(40.48) 997(56.52)
aThe percentage means the proportion of MDR isolates within each serotype.



















Pulsed field gel electrophoresis
Among the 1179 isolates of Salmonella analyzed by PFGE,
513 different PFGE profiles were observed (Table 3). Each
serovar corresponded to a single clade, while a few isolates
could be clustered into other serovar clades (data not
show). For the Salmonella Typhimurium and Salmonella
4,5,12:i:- complex clades, 286 PFGE profiles were ob-
served. The PFGE profile, JPXX01.GD0004, was most
prevalent, occurring in 21.37% (150/694) of isolates. For
Salmonella Enteritidis, profiles JEGX01.GD0006 (n = 50,
21.55%) and JEGX01.GD0007 (n = 50, 21.55%) were the
most common patterns. For Salmonella Stanley, the
JNGX01.GD0006 and JNGX01.GD0007 profiles were
most common patterns, while no predominant PFGE pat-
terns were observed either in Salmonella Derby (24 PFGE
profiles) or other serovars (53 PFGE profiles). The associ-
ation analysis among the predominant PFGE patterns,
MDR, age and geographic location showed that ACSSuT
was the predominant MDR pattern in the Salmonella
Typhimurium & S. 4,5,12:i:-complex clade, while ASSuT-
Nal (nalidixic acid)and ASSu-Nal were the predominant
MDR profiles in Salmonella Enteritidis. No dominant
MDR patterns were observed in Salmonella Stanley, Sal-
monella Derby or other serovars (Table 3). The predomin-
ant PFGE patterns of the Salmonella Typhimurium & S.
4,5,12:i:-complex clade and Salmonella Stanley mainly
prevalent in infants (<6 years). However, no obvious
relationship was observed between the PFGE profiles and
geographic location (Table 3).
Discussion
The current study indicated the serovar profiles of Sal-
monella enterica in diarrheal outpatients, and confirmed
widespread MDR and reduced ciprofloxacin and third-
generation cephalosporin susceptibility among NTS isolates
from Guangdong province. Although typhoid Salmonella
occurred in a few cases, most of them showed no resistance
to ciprofloxacin or third-generation cephalosporins. These
results were in agreement with the general knowledge of
the epidemiology of salmonellosis [6].
The serovar profile data showed that Salmonella Typhi-
murium became the dominant serovar in 2008. Salmonella
4,5,12:i:- is a monophasic variant of Salmonella Typhimur-
ium, which is very similar at the molecular level [24,25].
Therefore, the complex group of Salmonella Typhimurium
& 4,5,12:i:- ranked first in endemic serovars of Salmonella
in Guangdong. These data differ from those in Europe and
Latin America where Salmonella Enteritidis is the most
common serovar, followed by Salmonella Typhimurium
[26,27]. In contrast, the Guangdong data agree with those
in Africa and North America where Salmonella Typhimur-
ium seems to be more common than Salmonella Enteritidis
[28]. However, we still do not know the exact reasons for
this shifting from Salmonella Enteritidis to Salmonella
Figure 4 The ratio of resistant isolates in 2007 vs 2012 (A), and the association of MDR isolates within top 5 serovars with time (B) and
age (C). The red arrows showed the dramatic upgoing of the proportion of resistant isolates among total isolates (A). In panel B and C, Each data
point means the proportion of MDR isolates in the present year, different serovar are indicated using different symbols as illustrated in figure.
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Typhimurium and Salmonella 4,5,12:i:-. As we know, Sal-
monellaTyphimurium can be found in a wide range of ani-
mal species and is most commonly observed in pigs, while
the most common reservoirs of Salmonella Enteritidis are
eggs and chickens [29]. Therefore, it seems likely that the
wider reservoir pattern for Salmonella Typhimurium and
Salmonella 4,5,12:i:- provides them with more opportun-
ities to come in contact with people and other reservoirs,
resulting in the fast expansion of these two serovars. An-
other possible explanation for the increased detection of
Salmonella Typhimurium and Salmonella 4,5,12:i:- in
Guangdong is the updated training program for sampling
and culture in 2009. After training, the total number of
sampling and isolates increased significantly in 2009
(Table 1). Meanwhile, we found that both Salmonella
Typhimurium and Salmonella 4,5,12:i:- affected infants,
whereas Salmonella Enteritidis affected adults. The differ-
ent eating habits of infants and adults or special host adap-
tations may explain the observed distribution pattern.
Salmonella Stanley and Derby were also commonly found
in Guangdong as observed in other regions of the world
[26,28]. Several other serovars that are common in many
countries were also found in Guangdong, such as Salmon-
ella Rissen, Salmonella Weltevreden, Salmonella Infantis,
Salmonella Agona, Salmonella Albany and Salmonella
Newport [26,28]. Likely, the frequent global travel, commu-
nication and trading that occur in Guangdong favor the
transmission of these serovars, as similar trends have been
verified in Asia [30], Africa and Europe [31].
The antimicrobial susceptibility analyses cover antimicro-
bial resistance patterns in 15 of 21 cities in Guangdong
where the Salmonella situation had been poorly char-
acterized. Indeed, previous data about Salmonellosis in
Guangdong comprise few studies [15-18]. Comparing
these studies illustrates the emergence of antimicrobial re-
sistance except for the dramatic increase of resistance to
ciprofloxacin and third-generation cephalosporins, which
we have summarized in Guangdong province for the first
time here. A similar increase in resistance to antibiotics
was observed in fish and chicken in Guangdong [32]. The
Table 3 The association analysis among predominant PFGE patterns in each serovar, MDR, age and geography location
S. Typhimurium & S. 4,5,12:i:- S. Enteritidis S. Stanley S. Derby Others serovars
Number of PFGE pattern (n) 286(n = 702)a 78(n = 232) 72(n = 150) 24(n = 28) 53(n = 77)
Predominant PFGE pattern (n, %)b JPXX01.GD0004 JEGX01.GD0006 JNGX01.GD0006 None None
(n = 150, 21.37%) (n = 50, 21.55%) (n = 23, 15.33%)
JEGX01.GD0007 JNGX01.GD0007
(n = 50, 21.55%) (n = 29, 19.33%)
Age ≤ 6 years 141 51 44
>6 years 9 49 8












MDR pattern (n, %)c ACSSuT (99, 66.00%) JEGX01.GD0006 JNGX01.GD0006
None None
JEGX01.GD0007 JNGX01.GD0007
ASSuT-Nal (30, 30%) None
ASSu-Nal (17, 17%)
an = number of isolates which PFGE data available.
bn = number of isolates in the predominant PFGE pattern, % = percentage in isolates with PFGE data.
cn = number of MDR isolates in the predominant PFGE pattern, % = percentage in predominant PFGE pattern isolates.
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observed antibiotic resistance trend in Guangdong is very
similar to those described in the Guangxi [33] and Henan
provinces [14] in China. The major difference is the higher
ciprofloxacin resistance observed in Henan than Guangdong
(54% vs 8.05%). Meanwhile we found resistance to both cip-
rofloxacin and cephalosporins in Salmonella Typhimurium,
Salmonella 4,5,12:i:- and Salmonella Enteritidis. Ciprofloxa-
cin is currently the recommended the first-line antibiotic by
the World Health Organization for the treatment of sal-
monellosis [34]. Third-generation cephalosporins are
considered alternative drugs for salmonellosis treatment
[34]. Hence, the resistance to fluoroquinolones and
third-generation cephalosporins will pose a great challenge
for the effective treatment of salmonellosis. Particularly,
the dramatic increase of resistance to ciprofloxacin and
third-generation cephalosporins in infants is a warning sig-
nal for a prudent application of these antibiotics in clinical
settings. This situation in Guangdong seems completely dif-
ferent from particular areas in Africa where Salmonella are
highly susceptible to antibiotics [35]. Therefore, close sur-
veillance of Salmonella and their microbial resistance pat-
terns is essential to prevent the expansion of MDR clonal
populations [36]. Furthermore, the reduced ciprofloxacin
susceptibility was, in all cases, associated with nalidixic acid
resistance. Therefore, the detection of nalidixic acid resist-
ance remains a valuable test to screen for reduced cipro-
floxacin susceptibility in Guangdong.
PFGE typing implicated a relatively high diversity in all
serotypes, indicating that the human cases were most likely
sporadic; this interpretation agrees with unrelated epi-
demiological background of all of the cases [37]. We found
few dominant PFGE patterns in past and recent isolates of
Salmonella Typhimurium, Salmonella 4,5,12:i:-, Salmonella
Enteritidis and Salmonella Stanley. Thus, these common
patterns seem to have been constant over time. Meanwhile,
resistant patterns of each predominant PFGE pattern also
differed from each other. Therefore, the different PFGE pat-
terns perhaps came from different clonal lineage. Even so,
the obtained PFGE profiles and representative strains are
available for comparison with profiles obtained of Salmon-
ella from other countries to track the asymptomatic car-
riers and identify the circulation of major clones worldwide.
However, as we did not determine the genotype (such as
MLST or MLVA) of the dominant serovars, such as in the
Salmonella Typhimurium and Salmonella 4,5,12:i:- isolates,
we do not know if these serovars belong to the same line-
ages that are found in other continents; therefore, it would
be of crucial importance to determine the genotype to link
the possible transmission pathway of each predominant ser-
ovar in future studies [38].
Conclusion
In conclusion, Salmonella Typhimurium and Salmonella
4,5,12:i:- were the most common serovars isolated during
the observation period from 2007 to 2012 in Guangdong,
mainly causing salmonellosis in infants, whereas Salmon-
ella Enteritidis mainly caused salmonellosis in adults. In
2008, a serovar shift from Salmonella Enteritidis to Sal-
monella Typhimurium became apparent. A high burden
of multidrug resistant strains and an increasing incidence
of quinolone and third-generation cephalosporin resist-
ance were observed. Close surveillance of Salmonella and
their microbial resistance patterns, using combined mo-
lecular tools, such as PFGE, multilocus sequence typing
(MLST) and multiple locus VNTR analysis (MLVA), is
therefore dedicate to prevent outbreaks of disease, track
the potential transmission pathways and rationalize the
antimicrobial therapy of salmonellosis.
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